raloxifene hydrochloride has been researched along with Vitamin K Deficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jouyama, K; Matoba, K; Mokuda, S; Okuda, Y; Onishi, M; Sawada, N; Takasugi, K; Yamada, A | 1 |
| Carey, EJ; Yadav, A | 1 |
1 review(s) available for raloxifene hydrochloride and Vitamin K Deficiency
| Article | Year |
|---|---|
Osteoporosis in chronic liver disease.
Topics: Absorptiometry, Photon; Adrenal Cortex Hormones; Bilirubin; Bone Density; Calcitonin; Calcium, Dietary; Diphosphonates; Humans; Insulin-Like Growth Factor I; Liver Diseases; Malnutrition; Motor Activity; Osteoporosis; Raloxifene Hydrochloride; RANK Ligand; Risk Factors; Tumor Necrosis Factor-alpha; Vitamin D; Vitamin K Deficiency | 2013 |
1 other study(ies) available for raloxifene hydrochloride and Vitamin K Deficiency
| Article | Year |
|---|---|
Post-menopausal women with rheumatoid arthritis who are treated with raloxifene or alendronate or glucocorticoids have lower serum undercarboxylated osteocalcin levels.
Topics: Aged; Aged, 80 and over; Alendronate; Arthritis, Rheumatoid; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Glucocorticoids; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Severity of Illness Index; Vitamin K Deficiency | 2012 |